Lupus erythematosus, scleroderma and dermatomyositis (CROSBI ID 68823)
Prilog u knjizi | stručni rad | međunarodna recenzija
Podaci o odgovornosti
Marinović, Branka ; Pašalić, Marijan ; Balić, Anamaria ; Bukvić Mokos, Zrinka
engleski
Lupus erythematosus, scleroderma and dermatomyositis
This chapter focuses on three collagen diseases with prominent manifestations on the skin and which can affect the heart—lupus erythematosus, scleroderma and dermatomyositis. Systemic lupus erythematosus (SLE) is a typical example of an autoimmune disorder with multiorgan involvement and a wide variety of clinical manifestations. The skin is affected in 80% of SLE patients, most commonly with a clinical picture of acute cutaneous lupus erythematosus. Cardiovascular manifestations affect over 50% of patients with SLE, and the most common are pericarditis and pericardial effusion which are included in the current diagnostic criteria set. In scleroderma the most pronounced skin lesions are Raynaud syndrome, diffuse sclerosis of the skin and sclerodactyly. Pericardial involvement is a very common cardiac symptom in scleroderma. Dermatomyositis as a disease primarily affecting the skin and striated muscles, so besides the skin it often affects heart. The diagnostic approach in all of these diseases is based on history of the disease, clinical picture and laboratory findings as well as cardiovascular diagnostics when needed. In this chapter a topical as well as systemic therapeutic approach to each of the diagnoses is described.
lupus erythematosus ; scleroderma ; dermatomyositis ; skin ; heart
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
125-142.
objavljeno
10.1007/978-3-030-54779-0_9
Podaci o knjizi
Skin and the heart
Salavastru, Carmen ; Murrell, Dedee F. ; Otton, James
Cham: Springer
2021.
978-3-030-54778-3
Povezanost rada
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje), Kliničke medicinske znanosti